Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
BMC Cancer|January 23, 2021
The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision makingI Whitehead, G W Irwin, F Bannon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2015
Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†V Speirs, G Viale, K Mousa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2012
An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study)R C Coombes, T Tat, M L Miller, et al.
Breast Cancer Research and Treatment|November 15, 2014
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancerC Palmieri, S Cleator, L S Kilburn, et al.
Journal of the American College of Cardiology|April 1, 1996
The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study GroupsA Pingitore, E Picano, M Q Colosso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.
ESMO Open|May 16, 2022
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task ForceE Razis, M J Escudero, C Palmieri, et al.
ESMO Open|January 5, 2021
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcomeR J Lee, O Wysocki, T Bhogal, et al.
Pageof 13